Skip to main content
U.K. Edition
Sunday, 5 May 2024

Monday 3/15 Insider Buying Report: ICPT, DBX

Duration: 00:53s 0 shares 1 views

Monday 3/15 Insider Buying Report: ICPT, DBX
Monday 3/15 Insider Buying Report: ICPT, DBX

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

At Intercept Pharmaceuticals, a filing with the SEC revealed that on Friday, Director Srinivas Akkaraju purchased 237,000 shares of ICPT, at a cost of $21.17 each, for a total investment of $5.02M.

So far Akkaraju is in the green, up about 12.7% on their buy based on today's trading high of $23.86.

Intercept Pharmaceuticals Inc is trading up about 11.7% on the day Monday.

And at Dropbox, there was insider buying on Wednesday, by Robert J.

Mylod Jr. who purchased 100,000 shares for a cost of $24.59 each, for a trade totaling $2.46M.

This buy marks the first one filed by Mylod Jr. in the past year.

Dropbox is trading up about 3.4% on the day Monday.

So far Mylod Jr. is in the green, up about 14.9% on their buy based on today's trading high of $28.25.

You might like

Related news coverage

Advertisement

More coverage